1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Torvutatug samrotecan: new trials by email Literature Review of Torvutatug samrotecan trials Research Report on Torvutatug samrotecan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors Torvutatug samrotecan, Saruparib, Bevacizumab - Ovarian Cancer, Lung Adenocarcinoma | Phase 1 / Phase 2 | Recruiting | AstraZeneca | 622 | 2023-06-05 | 2026-10-05 |
Adenocarcinoma of Lung (1) · Endometrial Neoplasms (1) · Ovarian Neoplasms (1)
AstraZeneca (1)
Australia (1) · Canada (1) · China (1) · Germany (1) · Israel (1) · Japan (1) · South Korea (1) · Spain (1) · Taiwan (1) · Turkey (Türkiye) (1) · United Kingdom (1) · United States (1)